Kymera patent
Tīmeklis2024. gada 30. okt. · Today we’ve announced the launch of a new company, Kymera Therapeutics, which aims to create a world-leading therapeutics platform in this emerging field, ... Our patent strategy, which also includes novel ligands to E-3 ligases, protects these insights. We’ve also brought full-scale proteomics into the early … TīmeklisDirector, Intellectual Property at Kymera Therapeutics Greater Boston. 2K followers 500+ connections. Join to view profile ... Registered Patent Attorney USPTO Recommendations received ...
Kymera patent
Did you know?
TīmeklisDescription. Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. TīmeklisComputer Vision solutions for your company Discover how AI solutions can improve your products free DEMO USE CASES Kimera Technologies is a precise, easy-to …
TīmeklisEuropean Patent Office Prior art keywords same bifunctional compounds cereblon ligands cereblon ligands Prior art date 2024-01-31 ... Kymera Therapeutics, Inc. Proteinabbaumittel und verwendungen davon WO2024140387A1 (en) 2024-01-12: 2024-07-18: Kymera Therapeutics, Inc. Crbn ligands and uses thereof ... TīmeklisWe claim: 1. A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: IRAK is an IRAK binding moiety capable of binding to one or more of IRAK-1, -2, -3, or -4; L is a bivalent moiety that connects IRAK to LBM; and LBM is a ligase binding moiety. 2. The compound of claim 1, wherein LBM is a cereblon binding …
TīmeklisKymera Therapeutics, Inc. Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no … Tīmeklis2024. gada 4. sept. · The KYMERA INDEPENDENT PHYSICIANS trademark was assigned a Serial Number # 87766444 – by the United States Patent and Trademark Office (USPTO). Assigned Trademark Serial Number is a Unique ID to identify the KYMERA INDEPENDENT PHYSICIANS trademark application in the USPTO.. The …
Tīmeklis2024. gada 1. febr. · The patent applications also claimed that these PROTACs can degrade different proteins and provide a good strategy for treating diseases such as cancer. 5. The advantages of PROTACs. Traditional small molecule inhibitors have many limitations. The selection pressure of small molecule kinase inhibitors often …
TīmeklisKymera Therapeutics Apr 2024 - Jan 2024 10 months. Cambridge, Massachusetts, United States ... Associate / Patent Agent / … sbsondemand - the abyssTīmeklis2024. gada 17. dec. · Patents Assigned to KYMERA THERAPEUTICS, INC. IRAK degraders and uses thereof. Patent number: 11591332 Abstract: The present … sbsp fsx downloadTīmeklisKymera Therapeutics, Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no … Discuss; 102000004169 proteins and genes Human genes 0.000 title claims abstract … sbson demand.comTīmeklis2024. gada 3. nov. · Kymera has pocketed $150 million in up-front payments and stands to gain up to $2 billion in milestones from Sanofi to co-develop a targeted … sbsp chartsTīmeklis2024. gada 21. aug. · Kymera Therapeutics (NASDAQ: KYMR) is a biotechnology company that develops an approach to treating previously untreatable diseases. Use the CB Insights Platform to explore Kymera Therapeutics's full profile. ... Kymera Therapeutics has filed 24 patents. The 3 most popular patent topics include: … sbsp icaoTīmeklis2012. gada 26. sept. · The Kymera body board weighs 48 lbs (21 kg) The Kymera will come in two different sizes aimed at the recreational market, with each offering a choice of two different power options. A 5’6” (1. ... sbsp primary schoolTīmeklis2024. gada 6. marts · Targeted degraders first entered the patent literature in 1999, ... Kymera’s targeted protein degrader of IRAK4 demonstrates another set of near-term opportunities for the targeted … sbsp meaning